Abstract
Gastric cancer is one of the most common malignant tumors worldwide. The incidence of gastric cancer in East Asia, including Korea and Japan, is higher than in other regions, so the screening system in these regions has evolved to diagnose those with gastric cancer at an early stage. 1 Therefore, the proportion of patients with early gastric cancer (EGC) in these areas has recently increased. Patients with EGC have an excellent prognosis after curative resection, owing to low rates of lymph node metastasis and distant recurrence in the peritoneum and liver relative to patients with advanced-stage gastric cancer. Because lymph node metastasis is limited to a small number of perigastric lymph nodes even in EGC, some patients have been treated with limited (D1þ) lymphadenectomy. 2 In contrast with standard surgical procedures that include extended (D2) lymphadenectomy for gastric cancer, D1þ lymphadenectomy can be easily performed to reduce postoperative morbidity. 3 However, despite this, a total or subtotal gastrectomy should still be performed for EGC because a D1þ lymphadenectomy includes lymph nodes around the major vessels feeding the stomach. Extensive gastric resection that includes resection of the pylorus and autonomic nerve fibers can have a negative impact on quality of life after surgery, owing to reflux gastritis and uncontrolled bowel movements. Considering the long survival time of patients with EGC, function of the stomach should be maintained after complete resection of gastric cancer. One of the evolving modalities to maintain gastric function after removal of gastric cancer is endoscopic resection. Although endoscopic resection has been reserved for patients with EGC who are very unlikely to have metastatic lymph nodes, the proportion of gastric cancer patients treated with endoscopic resection has gradually increased as more patients are being diagnosed with EGC. 4 Development of the endoscopic resection technique can eliminate the limitation with regard to the range of en bloc resection in cases of mucosal cancers without metastatic lymph nodes, and furthermore expand the depth of resection into the submucosal layer. 5 Therefore, several gastroenterologists have been performing endoscopic resections using the extended criteria for this procedure suggested by previous reports. 2,6 However, despite the many benefits regarding quality of life, the temerarious use of endoscopic resection should be limited due to the lack of clinical evidence and limited ability for the identification of metastatic lymph nodes. On the other hand, if it becomes possible to confirm lymph node status and to perform minimal lymph node dissection for patients with EGC who meet the expanded indications for endoscopic treatment, then local resection
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.